title: ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin.
authors.affiliation: Department of Hematology/Oncology, National University Cancer Institute Singapore (NCIS), 5 Lower Kent Ridge Rd, Singapore, Singapore, 119074. bilal_abid@hotmail.com.
authors.forename: Muhammad Bilal
authors.identifier: http://orcid.org/0000-0002-1128-0445
authors.initials: MB
authors.lastname: Abid
authors.affiliation: Department of Pathology, National University Hospital Singapore (NUHS), Singapore, Singapore.
authors.forename: Shi
authors.initials: S
authors.lastname: Wang
authors.affiliation: Department of Nuclear Medicine, National University Hospital Singapore (NUHS), Singapore, Singapore.
authors.forename: Hoi Yin
authors.initials: HY
authors.lastname: Loi
authors.affiliation: Department of Hematology/Oncology, National University Cancer Institute Singapore (NCIS), 5 Lower Kent Ridge Rd, Singapore, Singapore, 119074.
authors.forename: L M
authors.initials: LM
authors.lastname: Poon
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology*; D000079963:Brentuximab Vedotin; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D000072078:Positron Emission Tomography Computed Tomography; D012008:Recurrence; D012074:Remission Induction; D016879:Salvage Therapy
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin